Here are six points:
1. The market was worth $1.2 billion in 2016.
2. Technological advancements — like subcutaneous implantable cardioverter-defibrillators, bioabsorbable stents, personalized joint replacements and leadless pacemakers — are spurring the next generation implants market growth.
3. Minimally invasive procedures and 3-D printed technology are also boosting the market.
4. North America led the market because of an increasing geriatric population and greater disease prevalence.
5. The global conventional medical implants market will likely reach $106.9 billion by 2023.
6. In 2016, the orthopedic segment dominated the conventional implant market, accounting for $34.74 billion.
More articles on devices:
CMS proposes changes to CJR bundled payments: 5 things to know
Stryker Spine receives FDA clearance for Serrato Pedicle Screw: 5 key notes
FDA clears Camber Spine Technologies’ SPIRA Open Matrix ALIF: 5 highlights
